+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Topical Corticosteroids Market 2023-2027 - Product Thumbnail Image

Topical Corticosteroids Market 2023-2027

  • Report
  • May 2023
  • 157 Pages
  • Global
From
IVF Devices Market 2024-2028 - Product Thumbnail Image

IVF Devices Market 2024-2028

  • Report
  • October 2023
  • 161 Pages
  • Global
From
From
Bioengineered Protein Drugs - Global Strategic Business Report - Product Thumbnail Image

Bioengineered Protein Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
Global Markets for Bioengineered Protein Drugs - Product Thumbnail Image

Global Markets for Bioengineered Protein Drugs

  • Report
  • March 2023
  • 185 Pages
  • Global
From
Bronchitis - Pipeline Insight, 2024 - Product Thumbnail Image

Bronchitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Keytruda (pembrolizumab; Merck & Co) Drug Overview 2019 - Product Thumbnail Image

Keytruda (pembrolizumab; Merck & Co) Drug Overview 2019

  • Drug Pipelines
  • September 2019
  • 141 Pages
  • Global
From
US Urinary Tract Infection Therapeutics outlook to 2028 - Product Thumbnail Image

US Urinary Tract Infection Therapeutics outlook to 2028

  • Report
  • August 2023
  • 85 Pages
  • United States
From
From
From
Loading Indicator